In Burkina Faso, around 1.5 million people have or are at high risk of heart disease. Cardiovascular disease (CVD) is responsible for around one-in-three deaths - approximately 20,600 each year - and more than from any other NCD. Continue reading →

Oral combination therapy does not appear to help achieve or maintain low risk status in most treatment-naive patients with pulmonary arterial hypertension (PAH), according to the results of a recent study published in the American Journal of Respiratory and Critical Care Medicine. Treatment-naive patients with PAH received combination oral therapy consisting of endothelin receptor antagonist (ERA) and phosphodiesterase-5 inhibitor (PDE-5i) medications Continue reading →

Racial and ethnic minoritized populations bear a disproportionate burden of illness and death as the COVID-19 pandemic continues in the U.S. These inequities are caused by larger determinants of health, such as lack of access to care, cultural bias in clinical decisions, structure of delivery systems, and structural racism. To begin to tackle inequities in care, health systems and medical groups must understand whom they are serving, the collection of accurate sociodemographic data, such as race and ethnicity data is critical Continue reading →

Nighttime nasal high flow therapy (NHF) at 20 L/min reduced sympathetic drive, most likely through washout of anatomical dead space, in patients with precapillary pulmonary hypertension (PH) and obstructive sleep apnea (OSA), according to study results published in Sleep and Breathing. Pharmacologic treatment of PH may restore sympathovagal balance (SVB), at least partially. Continue reading →

High blood pressure is the catalyst for many serious health problems yet it often goes undetected. When the force of blood pushing against your artery walls is consistently too high, it can cause them to narrow, rupture or leak. This can allow fatty plaques called cholesterol to build up in your arteries - a precursor to heart disease Continue reading →

The report is an all-inclusive research study of the global Pulmonary Arterial Hypertension Treatment market taking into account the growth factors, recent trends, developments, opportunities, and competitive landscape. The market analysts and researchers have done extensive analysis of the global Pulmonary Arterial Hypertension Treatment market with the help of research methodologies such as PESTLE and Porters Five Forces analysis. They have provided accurate and reliable market data and useful recommendations with an aim to help the players gain an insight into the overall present and future market scenario Continue reading →

LONDON--(BUSINESS WIRE)--The global ambulatory blood pressure monitoring systems market is expected to grow by USD 36.58 million as per Technavio. This marks a significant market slow down compared to the 2019 growth estimates due to the impact of the COVID-19 pandemic in the first half of 2020. Continue reading →

Most people dying of COVID-19 have chronic health problems, a fact that has generated endless skepticism as the number of deaths attributed to the disease climbs closer to 200,000 nationwide. From the beginning, some have repeatedly noted that there are few pure COVID-19 deaths where no other contributing conditions present Continue reading →